Castle Biosciences, Inc. (CSTL)
38.90
-0.41
(-1.04%)
USD |
NASDAQ |
Dec 31, 16:00
38.91
+0.01
(+0.03%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (TTM): 49.73M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.05M |
| Delcath Systems, Inc. | 22.79M |
| Star Operating Cos., Inc. | -- |
| CorMedix, Inc. | 12.46M |
| CytoSorbents Corp. | 5.140M |